One in Seven Drug Supply Chain Issue Reports Tied to Drug Shortages
By Lori Solomon HealthDay Reporter
WEDNESDAY, April 10, 2024 -- One in seven reports of drug supply chain issues are associated with drug shortages, according to a study published online April 5 in JAMA Network Open.
Katherine Callaway Kim, from University of Pittsburgh School of Medicine, and colleagues estimated the proportion of supply chain issue reports the U.S. Food and Drug Administration or the American Society of Health-Systems Pharmacists associated with drug shortages overall and with the COVID-19 pandemic. The analysis included data from the IQVIA Multinational Integrated Data Analysis database, comprising more than 85 percent of drug purchases by U.S. pharmacies from wholesalers and manufacturers (2017 to 2021).
The researchers identified 571 drugs exposed to 731 supply chain issue reports, which were matched to 7,296 comparison medications with no reports. When accounting for drug characteristics, 13.7 percent of supply chain issue reports were associated with subsequent drug shortages versus 4.1 percent of comparators (marginal odds ratio [mOR], 3.7). For both drugs with and without reports, shortages increased in February to April 2020 (34.2 percent of drugs with supply chain issue reports and 9.5 percent of comparison drugs; mOR, 4.9). These shortages then decreased after May 2020 (9.8 and 3.6 percent, respectively; mOR, 2.9). There were significant associations by formulation (parenteral mOR, 1.9 versus oral mOR, 5.4), by World Health Organization essential medicine status (essential mOR, 2.2 versus nonessential mOR, 4.6), and for brand-name versus generic status (brand-name mOR, 8.1 versus generic mOR, 2.4).
"These findings suggest that ongoing policy work is needed to protect U.S. drug supplies from future supply shocks," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Long COVID Definitions, Care Models Are Evolving
MONDAY, May 20, 2024 -- Definitions of long COVID and care models are evolving, but considerable variability is seen in these models, according to a review published online May 21...
Recommendations Developed for People With HIV Wanting to Breastfeed
MONDAY, May 20, 2024 -- In an American Academy of Pediatrics clinical report published online May 20 in Pediatrics, recommendations are presented for breastfeeding among people...
Social Determinants of Health Impact Poststroke Mortality Risk
MONDAY, May 20, 2024 -- Social determinants of health have a cumulative impact on poststroke mortality, according to a study presented at the the annual European Stroke...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.